风湿科门诊痛风患者结构化评估后的心血管风险研究
该横断面研究纳入237例晶体确诊的痛风新患者,采用SCORE和FHS两种工具进行心血管风险分层,并对非极高危者行颈动脉超声。结果显示极高危占40.1%、中危占30.5%,142例超声中46.5%发现粥样斑块,据此极高危比例升至67.9%。
要点
- 痛风新患者中极高危心血管风险占40.1%,中危占30.5%。
- 颈动脉超声在非极高危患者中检出斑块率达46.5%。
- SCORE与FHS对颈动脉斑块的预测能力仅为中等。
核心结论
- 多数痛风患者可能处于极高心血管风险,需在此阶段启动最优预防策略。
- 风险预测工具可能低估痛风患者颈动脉斑块的存在。
研究设计与样本
- 横断面研究,连续纳入237例晶体确诊的痛风新患者。
- 所有患者接受结构化心血管评估,包括心血管事件、危险因素及SCORE和FHS两种风险预测工具。
- 对低于极高危的患者行颈动脉超声检查。
主要发现
- 风险分层显示极高危95例(40.1%),中危72例(30.5%)。
- 142例接受颈动脉超声的患者中,66例(46.5%,95%CI 37.8至54.2)发现粥样斑块。
- 根据超声结果,极高危患者比例从40.1%升至67.9%(161/237例)。
- SCORE和FHS对颈动脉斑块的预测能力为中等(AUC分别为0.711和0.683)。
关键数值与推荐
- 心血管风险按现行欧洲指南进行分层。
- 颈动脉斑块的存在依据SCORE和FHS通过受试者工作特征曲线下面积(AUC)进行研究。
临床怎么用
- 对痛风新患者应进行结构化心血管风险评估。
- 对非极高危的痛风患者可考虑颈动脉超声以发现亚临床动脉粥样硬化。
- 风险预测工具可能低估斑块负荷,需结合影像学评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Gout-associated cardiovascular (CV) risk relates to comorbidities and crystal-led inflammation. The aim was to estimate the CV risk by prediction tools in new patients with gout and to assess whether ultrasonographic carotid changes are present in patients without high CV risk. METHODS: Cross-sectional study. Consecutive new patients with crystal-proven gout underwent a structured CV consultation, including CV events, risk factors and two risk prediction tools-the Systematic COronary Evaluation (SCORE) and the Framingham Heart Study (FHS). CV risk was stratified according to current European guidelines. Carotid ultrasound (cUS) was performed in patients with less than very high CV risk. The presence of carotid plaques was studied depending on the SCORE and FHS by the area under the curve (AUC) of receiver operating curves. RESULTS: 237 new patients with gout were recruited. CV stratification by scores showed a predominance of very high (95 patients, 40.1%) and moderate (72 patients, 30.5%) risk levels. cUS was performed in 142 patients, finding atheroma plaques in 66 (46.5%, 95% CI 37.8 to 54.2). Following cUS findings, patients classified as very high risk increased from 40.1% up to 67.9% (161/237 patients). SCORE and FHS predicted moderately (AUC 0.711 and 0.683, respectively) the presence of atheroma plaques at cUS. CONCLUSIONS: The majority of patients presenting with gout may be at very high CV risk, indicating the need for initiating optimal prevention strategies at this stage. Risk prediction tools appear to underestimate the presence of carotid plaque in patients with gout.
引用
- Andrés M, Bernal JA, Sivera F, et al. Cardiovascular risk of patients with gout seen at rheumatology clinics following a structured assessment. Ann Rheum Dis. 2017. PMID: 28093417. doi:10.1136/annrheumdis-2016-210357
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。